Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study
Start Date
9/10/2026
Completion Date
6/30/2028
Summary
This clinical trial is about prenatal genetic screening. It will test an intervention to help people make decisions about screening. The intervention is a short set of information cards about screening. This intervention is for pregnant participants. They will use the intervention on their mobile phone before they see their doctor. The study has one main question: * Do participants who use the intervention feel more confident when they make a decision about screening? Researchers will compare participants who use the intervention to participants who do not. All participants will have their usual care when they visit their doctor. What will participants do? * Participants must be pregnant. They will sign up for the study before their first doctor's visit for their pregnancy. This is the visit where their doctor usually talks with them about screening. * Some participants will use the intervention before their first doctor's visit. Other participants will not use it. * All participants will talk with a researcher on the phone after their first doctor's visit. * Participants who use the intervention will answer a short survey on their phone. * A few participants who use the intervention will talk with a researcher a second time on the phone.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Mobile-based Educational Intervention
Conditions
Locations
Zuckerberg Chan San Francisco General Hospital
San Francisco, California 94158
United States
University of Florida Health
Jacksonville, Florida 32209
United States
University of North Carolina
Chapel Hill, North Carolina 27599
United States